Ganglioside GM1 receptor (GM1)

The Ganglioside GM1 receptor is a sialic acid-containing glycosphingolipid primarily located in the outer leaflet of the plasma membrane, particularly within lipid rafts. It serves as the primary physiological receptor for several bacterial toxins, including the heat-labile enterotoxin (LT) from Escherichia coli and the cholera toxin from Vibrio cholerae. In the context of vaccine development, the interaction between detoxified LTh (human-type LT) and the GM1 receptor is exploited to enhance the immunogenicity of co-administered antigens. Binding to GM1 on dendritic cells and other immune cells promotes antigen uptake and cellular activation, making it a critical target for mucosal and systemic adjuvants. Beyond its role in toxin binding, GM1 is involved in various cellular processes, including signal transduction and neuronal protection. While highly effective at stimulating immune responses, targeting GM1 with LT-derived molecules requires careful detoxification to avoid enterotoxicity and specific delivery routes to mitigate risks like Bell's palsy.

Other names

GM1Monosialoganglioside GM1GM1aGal(beta1-3)GalNAc(beta1-4)(Neu5Ac(alpha2-3))Gal(beta1-4)Glc(beta1-1)CerHeat-labile enterotoxin receptor

Binds to Ganglioside GM1 receptors on the surface of immune cells (e.g., dendritic cells) to facilitate the internalization of antigens and trigger signaling pathways that promote cell maturation and cytokine production, thereby enhancing the adaptive immune response.